Senescence Life Sciences is a biotechnology company dedicated to redefining and optimizing brain health and performance.
Leveraging the latest advances in cellular and molecular neuroscience, we develop novel nutritional products and therapeutics products to address age-related cognitive decline and associated neurodegenerative diseases.
Our quality solutions are proven to aid in the recovery and optimization of cognitive performance.
Our products targets natural brain aging using a specific enzymatic process and cellular mechanism that has been shown to restore classical neuronal indicators of age – including learning, memory and decision-making performance.
Founded by Dr. Shawn Watson and supported by world-renowned scientists and business leaders, Senescence is the parent company of businesses that leverage Dr. Watson’s technology to combat brain-related cognitive challenges through a variety of formats.
